semaglutide side effects acid reflux reflux: why it happens and how to manage it Ozempic & the Gut: What

Sobo can better evaluate whether the plan is working, whether the dose should change, whether labs should be reviewed, or whether another approach may be more appropriate

Start at 0.51mg subcutaneously once daily in the morning for the first week, then titrate to 12mg based on tolerability and pigmentation response

Wegovy coverage depends on whether a plan includes weight-loss benefits, which many do not

Think of it as a team effort

What Reclassification Would (and Would Not) Change If BPC-157 is moved to Category 1 after the July 2026 meeting, the regulatory impact is narrower than many online summaries suggest: Scenario Category 2 (current default) Category 1 (post-reclassification) FDA approval No No 503A compounding Not permitted Permitted (pending final rulemaking) 503B outsourcing facilities Separate list (503B bulks list) Separate determination required Commercial drug product Not available Still not available without NDA Research/laboratory use Legal for research Legal for research (unchanged) In plain terms: Category 1 status lets a patient with a valid prescription get BPC-157 prepared by a state-licensed compounding pharmacy